@article{oai:nagasaki-u.repo.nii.ac.jp:00015430,
 author = {Takatsuki, Mitsuhisa and Eguchi, Susumu and Yamanouchi, Kosho and Hidaka, Masaaki and Soyama, Akihiko and Miyazaki, Kensuke and Tajima, Yoshitsugu and Kanematsu, Takashi},
 issue = {6},
 journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
 month = {Nov},
 note = {Objective: The objective of this study is to present results from our review of methicillin-resistant Staphylococcus aureus (MRSA) infection in living-donor liver transplant (LDLT) recipients. Methods: Seventy patients with primary LDLT between August 1997 and May 2007 were retrospectively reviewed. Results: Overall, 9 patients (12.9%) encountered various kinds of MRSA infection after transplantation [peritonitis (6), bacteremia (6), pneumonia (3), wound infection (3), cholangitis (1)]; 4 of these 9 patients died. Of these 4 expired patients, 3 were highly urgent cases with very poor pretransplant status under ventilator support. In one patient, linezolid was effective after teicoplanin failure for severe systemic MRSA infections (bacteremia, peritonitis, cholangitis, pneumonia, and enteritis). Of the 4 patients in whom MRSA was isolated only in a nasal swab before transplantation, none developed MRSA infection after transplantation with a 3-day course of mupirocin prophylaxis. Conclusions: MRSA infection was a contributing factor in death after transplantation in cases with poor pretransplant status. Linezolid was effective even for treating systemic MRSA infection after LDLT. A short course of mupirocin prophylaxis seemed to be effective and did not have any adverse effects., Journal of Hepato-Biliary-Pancreatic Sciences, 17(6), pp.839-843; 2010},
 pages = {839--843},
 title = {The outcomes of methicillin-resistant Staphylococcus aureus infection after living donor liver transplantation in a Japanese center},
 volume = {17},
 year = {2010}
}